4th COVID-19 Booster Recommended for those with Chronic Liver Disease

June 21, 2022

The Australian Technical Advisory Group on Immunisation (ATAGI) recommends a fourth COVID-19 vaccine dose for people with a range of immunocompromising conditions including chronic liver diseases such as cirrhosis, autoimmune hepatitis, non-alcoholic fatty liver disease, and alcoholic liver disease.

ATAGI said an extra winter booster should be given four months after the initial booster but should be delayed three months after a confirmed COVID-19 infection has cleared. Any Australian with a chronic, terminal, or severe illness, or those suffering from a significant disability are now eligible for the fourth dose. ATAGI also encourages those over 65 to consider the fourth dose during flu season. This new scheme aims to prevent poor outcomes of COVID-19 for those who are immunocompromised, during the winter months.

ATAGI has advised that the flu vaccine could still be given ahead of the additional booster for patients not yet eligible for a fourth dose.

ATAGI Booster Advice

LiverWELL acknowledges the support of the Victorian Government.

We welcome people from all cultures, nationalities and religions. Being inclusive and providing equitable services is our commitment.

ABN 48 656 812 701

We acknowledge the traditional owners of the lands where we work - the lands of the Woi-Wurrung Wurundjeri people of the Kulin Nations. We express our gratitude to them for their continued care and curation of these lands and waters. We pay our respects to Elders past and present.

LiverWELL observes and honours the Kulin Nation's intrinsic connection to land, sky and water, and the creator Bunjil. LiverWELL is committed to being led and informed by Aboriginal and Torres Strait Islanders on bridging health outcomes for communities and improving liver health.

Topics you might be interested in

4th COVID-19 Booster Recommended for those with Chronic Liver Disease

Continue reading